Navidea Biopharmaceuticals 뉴스 - NAVB

기업명	주식 심볼	시장	주식 타입
Navidea Biopharmaceuticals Inc	NAVB	AMEX	보통주

	가격 변동	가격 변동 %	주식 가격	최근 거래 시간
	0.00	0.00%	0.0779	09:00:00

개장가	저가	고가	종가	전일 종가
			0.0779	0.0779

시세 정보 더보기 »

최근 뉴스

일자	시간	출처	제목
22/12/2023	05:32	EDGAR2	Form SC 13D/A - General statement of acquisition of..
06/12/2023	08:26	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
02/12/2023	01:49	EDGAR2	Form 8-K - Current report
17/11/2023	06:55	EDGAR2	Form 8-K - Current report
24/10/2023	02:56	EDGAR2	Form 25-NSE - Notification filed by national security..
06/10/2023	10:01	BW	Navidea Biopharmaceuticals, Inc. Announces NYSE American’s..
06/10/2023	05:21	EDGAR2	Form DEF 14A - Other definitive proxy statements
16/09/2023	04:42	EDGAR2	Form PRE 14A - Other preliminary proxy statements
11/09/2023	13:15	EDGAR2	Form EFFECT - Notice of Effectiveness
16/08/2023	06:53	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
12/08/2023	05:06	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/2023	22:29	BW	Navidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing..
09/08/2023	05:23	EDGAR2	Form 8-K - Current report
31/07/2023	22:32	BW	Navidea Biopharmaceuticals, Inc. Presses Ahead, Embraces..
29/07/2023	09:23	BW	Navidea Biopharmaceuticals, Inc. Announces NYSE American Has..
29/07/2023	06:10	EDGAR2	Form 8-K - Current report
28/07/2023	06:20	BW	Navidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA as..
18/07/2023	07:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
18/07/2023	07:00	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
14/07/2023	06:27	EDGAR2	Form 8-K - Current report
14/07/2023	06:09	BW	Navidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to..
07/07/2023	05:39	EDGAR2	Form 8-K - Current report
04/07/2023	06:30	EDGAR2	Form DEF 14A - Other definitive proxy statements
04/07/2023	05:01	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
01/07/2023	05:01	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
30/06/2023	23:46	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
30/06/2023	22:16	BW	Navidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer..
17/06/2023	05:54	BW	Navidea Biopharmaceuticals, Inc. Announces Distribution of..
17/06/2023	02:52	BW	Navidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash..
08/06/2023	05:00	BW	Navidea Biopharmaceuticals, Inc. Reports First Quarter 2023..
03/06/2023	06:54	BW	Navidea Biopharmaceuticals, Inc. Receives NYSE American..
02/06/2023	06:53	BW	Navidea Biopharmaceuticals, Inc. Welcomes Jill Bieker..
23/05/2023	07:30	BW	Navidea Biopharmaceuticals, Inc. Investors Purchase $1.1..
12/05/2023	06:35	BW	Navidea Biopharmaceuticals, Inc. Promotes Michael Sherman..
09/05/2023	05:12	BW	Navidea Biopharmaceuticals, Inc. Drives Strategy Forward,..

이 » 주식의 기사 더보기;

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

NAVB Navidea Biopharmaceuticals Inc

최근 뉴스

NAVB 과거 데이터 - 1일

NAVB 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Navidea Biopharmaceuticals Inc (NAVB) 뉴스

NAVB Navidea Biopharmaceuticals Inc

최근 뉴스

NAVB 과거 데이터 - 1일

NAVB 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기